Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PPD Doubles Personnel For Internal Discovery Of Therapeutic Targets

Executive Summary

PPD has "nearly doubled" the number of full-time equivalents in its discovery unit dedicated to R&D for internal projects, CEO Fred Eshelman, MD, told analysts during an April 17 conference call.

You may also be interested in...



Quintiles/Orion Rx Development Venture Will Start With Three Phase II Drugs

A drug development venture being formed by the contract research organization Quintiles and the Finnish drug manufacturer Orion will start with at least three drugs in Phase II clinical trials

Quintiles/Orion Rx Development Venture Will Start With Three Phase II Drugs

A drug development venture being formed by the contract research organization Quintiles and the Finnish drug manufacturer Orion will start with at least three drugs in Phase II clinical trials

CROs Counting On Biotech Stock Rise, Phase IV Trials To Drive New Business

Recently enriched biotechnology companies will help the contract research organization market recover from its slump in the coming year, PPD CEO Fred Eshelman, MD, told analysts during an April 20 conference call.

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel